2026 BCOP Sprint Session 1 On Demand: UnPACCing Treatment of Uncommon EGFR Mutations
UAN: 0465-0000-26-106-H01-P
ACPE CE: 0.5
BCOP CE: 0.5
This course was published on August 23, 2026, and access to its materials expires at 11:59 PM US Central time, on September 23, 2027
All credits must be claimed before the end of September 23, 2027
Learning Objectives:
- Outline how structure-based classification of EGFR mutations can impact treatment selection for patients
- Explain the treatment landscape for first line treatment options in patients with EGFR PACC mutations, and including emerging and novel treatment options
Course Description:
This presentation will provide an overview of uncommon EGFR mutations in non-small cell lung cancer, focusing on PACC mutations. We will review a structure-based classification framework for EGFR mutations and how this influences drug binding, treatment sensitivity and therapeutic decision making. Participants will review current guidelines as well as emerging clinical evidence for the first line treatment of EGFR PACC mutations, including novel agents. Real world data, clinical trial data, and a case example will be used to highlight practical considerations in treatment selection and unmet needs in this patient population.
Application course for Pharmacists
Presenter:
Amanda Cass, PharmD, BCOP
Clinical Pharmacist Specialist, Thoracic Oncology
Requirements to Earn CE:
Begin by accessing the pre-test below. After the pre-test is complete, please complete the remainder of the course, including content, post-test, evaluation, credit claim and certificate of completion. In order to claim credit, all these activities must be completed.
Technology requirements:
HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content. HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.
Thank you to our accreditors:
HOPA would like to acknowledge the following content reviewers for their work on BCOP Sprint Session 1. Each is listed with their corresponding disclosure:
| Name | Disclosure |
| Michelle Worst | None |
| Melvin Rivera | Advisory Board for Nuvalent |
| Ivan Huang | None |